Vericel Corp

VCELNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$276.3M

▲ 16.5% YoY

Net Income

$16.5M

▲ 59.4% YoY

EPS

$0.32

▲ 60.0% YoY

Cash

$100.1M

▲ 34.3% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.